FARALLON CAPITAL MANAGEMENT LLC

Q1 2023 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
187
Total value ($000)
$17,671,594
Net value change ($000)
+2,415,330 (15.8%)
New positions
14
Sold out positions
41
Turnover %
16.2%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/14/2023 Next filing: 8/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co 591,519 NEW
SHAW COMMUNICATIONS INC 472,755 NEW
UNH 409,263 NEW
GOOGL 298,930 111.3%
EXEL 281,150 161.3%
CRM 198,296 39.6%
Oak Street Health, Inc. 174,179 NEW
Prometheus Biosciences, Inc. 102,178 640.2%
MSFT 75,803 18.7%
NOW 65,524 25.2%
Top Reduces (Value $000, Stocks/ETFs)
ABBV -151,786 -100.0%
CLVT -126,580 -100.0%
CNC -74,738 -19.8%
CVS -64,698 -100.0%
MA -54,573 -17.1%
BABA -50,483 -21.5%
EFX -47,611 -14.4%
ARMK -45,350 -10.1%
CYTK -44,963 -57.7%
BSX -42,978 -10.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,821,790 (10.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type